Covestor’s Fortress Biotech FBIO Stock Holding History

Covestor’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15	Closed	–	–	2212
2022 Q3	$0	Hold	15	–	–	﹤0.01%	2169
2022 Q2	$0	Hold	15	–	–	﹤0.01%	2059
2022 Q1	$0	Buy	15 +3	+25%	+$82	﹤0.01%	2212
2021 Q4	$0	Buy	+12	New	+$535	﹤0.01%	2174

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covestor's FBIO Position: Q4 2022 in Review

Covestor sold out of Fortress Biotech (FBIO) in Q4 2022, closing a stake of 15 shares.

Covestor first reported a position in FBIO in Q4 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 49 funds tracked by Wall St. Rank hold FBIO as of Q4 2022.

Covestor reported no remaining Fortress Biotech position as of Q4 2022 after selling out during the quarter.
Covestor sold 15 Fortress Biotech shares in Q4 2022.
Covestor first reported a position in Fortress Biotech in Q4 2021 and held it in 4 quarters.
Covestor's Fortress Biotech position peaked at $0 in Q3 2022.
49 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2022.

Based on Covestor's 13F filing for Q4 2022, filed 14 Feb 2023.